ACOG has reaffirmed guidance related to medication abortion up until 70 days of gestation. This guidance impacts multiple aspects of gynecologic care. Approximately 60% of abortions will occur before 10 weeks with current data suggesting that medication abortion constitutes 39% of all abortions. Combined mifepristone-misoprostol regimens are preferred due to increased effectiveness vs misoprostol only. Mifepristone is a selective progesterone receptor modulator and misoprostol is a prostaglandin E1 analogue.
- Provider:Postgraduate Institute for Medicine
- Activity Link: https://www.obgproject.com/2023/01/30/acog-guidance-for-medication-abortion-evaluation-dosing-and-follow-up/
- Start Date: 2024-01-01 06:00:00
- End Date: 2024-01-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest